Search

everythinglearnresearchcommunity

for

Search:↓

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Higher PSA levels are linked to more hirsutism in women with PCOS.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

No link found between hair loss severity and PSA levels in men.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Finasteride treats hair loss but may affect prostate cancer detection.

Seven genetic variations in sheep's DSG4 gene are linked and affect wool traits.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.